Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000195787 | SCV000253235 | likely benign | PTEN hamartoma tumor syndrome | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000581140 | SCV000686280 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001284055 | SCV000722461 | likely benign | not provided | 2019-02-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581140 | SCV001173477 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284055 | SCV001469635 | likely benign | not provided | 2020-08-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000581140 | SCV002528223 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-06 | criteria provided, single submitter | curation |